Greenwich LifeSciences (GLSI) Profit After Tax (2019 - 2026)

Greenwich LifeSciences (GLSI) has 7 years of Profit After Tax data on file, last reported at -$9.2 million in Q4 2025.

• Quarterly Profit After Tax rose 5.3% year-over-year to -$9.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$19.4 million (down 11.16% YoY) and the FY2025 annual result came in at -$19.4 million, down 11.16% from the prior year.
• Profit After Tax declined to -$9.2 million in Q4 2025, from -$3.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$597008.0 in Q1 2021 to a low of -$9.7 million in Q4 2024.
• A 5-year average of -$2.9 million and a median of -$2.4 million in 2023 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2021 — Profit After Tax tumbled 256.29% — and 2025, when it climbed 5.3%.
• Tracing GLSI's Profit After Tax over 5 years: stood at -$2.4 million in 2021, then dropped by 18.21% to -$2.8 million in 2022, then grew by 1.57% to -$2.7 million in 2023, then plunged by 251.89% to -$9.7 million in 2024, then gained by 5.3% to -$9.2 million in 2025.
• The last three Profit After Tax figures came in at -$9.2 million (Q4 2025), -$3.7 million (Q3 2025), and -$3.7 million (Q2 2025), per Business Quant data.